Status:
UNKNOWN
β-lactam Use in Single-stage Exchange of ProstheTic Infections (Knee / Hip) in a Center of Reference (β-SEPTIC)
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Infected of Hip or Kneeprosthesis
Eligibility:
All Genders
18+ years
Brief Summary
According to the official recommendations, infected prosthesis can be surgically treated by one or two-stage replacement. In Strasbourg, the investigators only perform one-stage surgery, which means t...
Eligibility Criteria
Inclusion
- Adults ( \> 18 years-old) hospitalized from 1st January 2018 to 31th December 2018 in the septic orthopedic surgery unity of the university hospital of Strasbourg for a prosthetic-joint infection (knee or hip) treated by replacement.
- Patients who mentioned they agree for scientific use of their medical data.
Exclusion
- Patients hospitalized only for the second surgery of a two-stage replacement.
- Patients who refused or didn't agree with scientific use of their medical data.
- Adults with legal protective measures.
Key Trial Info
Start Date :
June 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04123964
Start Date
June 27 2019
End Date
June 1 2021
Last Update
October 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Orthopédique Septique
Strasbourg, France, 67098